Collaboration - February 7, 2022
One step closer to a joint Nordic vaccine production
The Nordic countries are looking into starting joint vaccine production facilities to be prepared for future pandemics. Last year, Sweden took the initiative for Nordic co-operation, which will map the resources of both public and private companies when it comes to the development and production of vaccines in the Nordic region. “It’s about trying to […]
Biotech Business - January 12, 2022
Affibody and Lokon Pharma initiate collaboration
Lokon Pharma has announced a collaboration with Affibody to combine oncolytic viruses with Affibody molecules. “Lokon’s oncolytic adenovirus platform encodes human immunostimulatory genes to induce anti-tumor immunity in cancer patients. We already have one virus in clinical development, LOAd703, and we are expanding our pipeline to meet the demand of different types of malignancies” says […]
Collaboration - December 22, 2021
International center for stem cell-based research established in Copenhagen
The Novo Nordisk Foundation Center for Stem Cell Medicine reNEW, will be established based on a new consortium of three institutions. The founding of the center is possible through an unprecedented grant of up to 300 million euro from the Novo Nordisk Foundation over a 10-year period. The center will be a collaboration between the […]
Collaboration - December 22, 2021
Season’s Greetings from Nordic Life Science
We would like to thank our readers, subscribers and collaboration partners for a fruitful 2021, and we wish you all a most wonderful holiday season! 2021 has been – yet another – challenging year and we have reported about both global and Nordic efforts to handle, treat and prevent COVID-19. But we have also seen […]
Collaboration - December 22, 2021
Gedea receives funding for microbiome research project
Gedea Biotech has received funding for a research project with the Centre for Translational Microbiome Research at Karolinska Institutet (KI), for its lead product, pHyph, a vaginal tablet for topical treatment of bacterial vaginosis (BV). The project goal is to better understand the microbial etiology of bacterial vaginosis (BV) and factors associated with successful, antibiotic-free […]
Collaboration - November 30, 2021
Immunicum and PCI Biotech extend their collaboration
Immunicum and PCI Biotech Holding have announced an extension of their current research collaboration to explore novel cancer vaccination treatments. The companies jointly research the possibility to overcome current hurdles in cancer immunotherapy by introducing tumor independent immune targets into the tumor microenvironment, in combination with vaccination or adoptive immunotherapies. The so-called Tumor Independent Antigen […]
